{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Lymph&page=5", "query": { "condition": "Lymph", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 435, "total_pages": 44, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Lymph&page=6&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Lymph&page=4&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-19T09:03:26.814Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03733210", "title": "Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Squamous Cell Carcinoma of the Head and Neck", "Carcinoma of the Head and Neck" ], "interventions": [ { "name": "Panitumumab-IRDye800", "type": "DRUG" }, { "name": "89-Zirconium (Zr-89) Panitumumab", "type": "DRUG" }, { "name": "Pinpoint IR IR9000 fluorescence imaging system (FIS)", "type": "DEVICE" }, { "name": "SPY-PHI IR9000 fluorescence imaging system (FIS)", "type": "DEVICE" }, { "name": "Explorer Air camera", "type": "DEVICE" }, { "name": "PDE-NEO II camera", "type": "DEVICE" }, { "name": "FIS-00 fluorescence imaging system (FIS)", "type": "DEVICE" }, { "name": "Da Vinci Firefly Imaging System", "type": "DEVICE" }, { "name": "IGP-ELVIS-v4 Macroscopic Specimen Imager", "type": "DEVICE" }, { "name": "Vevo 3100 LAZR-X", "type": "DEVICE" }, { "name": "Pearl Triology Imaging System", "type": "DEVICE" }, { "name": "Odyssey CLx Imaging System", "type": "DEVICE" }, { "name": "Leica fluorescence microscope", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Andrei Iagaru", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 14, "start_date": "2019-01-07", "completion_date": "2021-08-09", "has_results": true, "last_update_posted_date": "2023-05-19", "last_synced_at": "2026-10-19T09:03:26.814Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03733210" }, { "nct_id": "NCT00005640", "title": "Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Colorectal Cancer" ], "interventions": [ { "name": "Preoperative Endoscopy", "type": "PROCEDURE" }, { "name": "Technetium Tc 99m Sulfur Colloid", "type": "RADIATION" }, { "name": "Gamma Probe", "type": "PROCEDURE" }, { "name": "Biopsy of Sentinel Lymph Nodes", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "RADIATION" ], "sponsor": "H. Lee Moffitt Cancer Center and Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "1999-06", "completion_date": "2002-02", "has_results": false, "last_update_posted_date": "2012-09-25", "last_synced_at": "2026-10-19T09:03:26.814Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00005640" }, { "nct_id": "NCT03796767", "title": "Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Recurrent Prostate Carcinoma", "Metastatic Malignant Neoplasm in the Bone", "Metastatic Malignant Neoplasm in the Lymph Nodes", "Oligometastasis", "Prostate Adenocarcinoma", "PSA Failure" ], "interventions": [ { "name": "Hypofractionated Radiation Therapy", "type": "RADIATION" }, { "name": "Intensity-Modulated Radiation Therapy", "type": "RADIATION" }, { "name": "Metastasectomy", "type": "PROCEDURE" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Stereotactic Body Radiation Therapy", "type": "RADIATION" } ], "intervention_types": [ "RADIATION", "PROCEDURE", "OTHER" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 20, "start_date": "2019-09-09", "completion_date": "2026-03-11", "has_results": true, "last_update_posted_date": "2026-07-22", "last_synced_at": "2026-10-19T09:03:26.814Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT03796767" }, { "nct_id": "NCT05019976", "title": "Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Non-hodgkin Lymphoma", "Hodgkin Lymphoma", "Lymphoma" ], "interventions": [ { "name": "Radiation - Dose Level 0", "type": "RADIATION" }, { "name": "Radiation - Dose Level 1", "type": "RADIATION" }, { "name": "Radiation - Dose Level 2", "type": "RADIATION" }, { "name": "Radiation - Dose Level 3", "type": "RADIATION" }, { "name": "Radiation - Dose Level 4", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2021-09-30", "completion_date": "2027-12-01", "has_results": false, "last_update_posted_date": "2025-12-29", "last_synced_at": "2026-10-19T09:03:26.814Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05019976" }, { "nct_id": "NCT02112240", "title": "Feasibility Study to Develop Sentinel Lymph Node Mapping in Rectal Cancer Patients", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Rectal Cancer" ], "interventions": [ { "name": "Intraoperative Mobile Gamma Camera imaging", "type": "OTHER" }, { "name": "Endoscopic injection of 99mTc-sulfur colloid", "type": "DRUG" }, { "name": "Endoscopic injections of Spot", "type": "OTHER" }, { "name": "Preoperative flexible sigmoidoscopy", "type": "PROCEDURE" }, { "name": "SPECT/CT", "type": "RADIATION" } ], "intervention_types": [ "OTHER", "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "University of Virginia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2013-05", "completion_date": null, "has_results": false, "last_update_posted_date": "2016-07-15", "last_synced_at": "2026-10-19T09:03:26.814Z", "location_count": 1, "location_summary": "Charlottesville, Virginia", "locations": [ { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02112240" }, { "nct_id": "NCT05236387", "title": "Evaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node Dissection", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "99m Tc-TM", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 14, "start_date": "2022-03-01", "completion_date": "2023-06-30", "has_results": false, "last_update_posted_date": "2024-02-09", "last_synced_at": "2026-10-19T09:03:26.814Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05236387" }, { "nct_id": "NCT02462226", "title": "Enhancing Management of Chronic Pain and Symptoms Among Women Treated for Breast Cancer (Lymph-Flow)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer", "Pain", "Lymphedema" ], "interventions": [ { "name": "The-Optimal-Lymph-Flow", "type": "BEHAVIORAL" }, { "name": "Arm Precaution", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "89 Years", "sex": "FEMALE", "summary": "21 Years to 89 Years · Female only" }, "enrollment_count": 120, "start_date": "2015-05-01", "completion_date": "2016-12-01", "has_results": false, "last_update_posted_date": "2017-04-20", "last_synced_at": "2026-10-19T09:03:26.814Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02462226" }, { "nct_id": "NCT06868238", "title": "Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ductal Carcinoma in Situ" ], "interventions": [ { "name": "Magtrace", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2026-10", "completion_date": "2029-06", "has_results": false, "last_update_posted_date": "2026-09-11", "last_synced_at": "2026-10-19T09:03:26.814Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06868238" }, { "nct_id": "NCT00416455", "title": "Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Cervical Adenocarcinoma", "Cervical Adenosquamous Cell Carcinoma", "Cervical Small Cell Carcinoma", "Cervical Squamous Cell Carcinoma", "Endometrial Clear Cell Carcinoma", "Endometrial Papillary Serous Carcinoma", "Stage I Endometrial Carcinoma", "Stage IB Cervical Cancer", "Stage II Endometrial Carcinoma", "Stage IIA Cervical Cancer", "Stage IIB Cervical Cancer", "Stage III Cervical Cancer", "Stage III Endometrial Carcinoma", "Stage IVA Cervical Cancer" ], "interventions": [ { "name": "fludeoxyglucose F 18", "type": "RADIATION" }, { "name": "positron emission tomography", "type": "PROCEDURE" }, { "name": "computed tomography", "type": "PROCEDURE" }, { "name": "ferumoxtran-10", "type": "DRUG" }, { "name": "magnetic resonance imaging", "type": "PROCEDURE" }, { "name": "diagnostic lymphadenectomy", "type": "PROCEDURE" }, { "name": "lymph node biopsy", "type": "PROCEDURE" } ], "intervention_types": [ "RADIATION", "PROCEDURE", "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 384, "start_date": "2007-09", "completion_date": "2016-07-16", "has_results": true, "last_update_posted_date": "2019-07-23", "last_synced_at": "2026-10-19T09:03:26.814Z", "location_count": 24, "location_summary": "Los Angeles, California • Sylmar, California • New Britain, Connecticut + 18 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sylmar", "state": "California" }, { "city": "New Britain", "state": "Connecticut" }, { "city": "Sarasota", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00416455" }, { "nct_id": "NCT00933426", "title": "Lenalidomide and Paclitaxel in Prostate Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Lenalidomide", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 17, "start_date": "2009-08", "completion_date": "2015-12", "has_results": false, "last_update_posted_date": "2016-10-26", "last_synced_at": "2026-10-19T09:03:26.814Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00933426" } ] }